In TME, the higher frequency of IFN-γ+CD8+CD226+TILs was correlated with up-regulated TIGIT expression, which could serve as an essential and potential biomarker to predict the progress and immune evasion in GC patients. This evidence concerns the gene TIGIT and gastric cancer.